Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2020

Jun 16, 2020

1671_mrq_2020-06-16_c0b9dbb7-3a80-49b7-9e46-eac34df7b225.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0918Q

Societe Generale SA

16 June 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 15/06/2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 256,488 0.20 8,307 0.01
(2) Derivatives (other than options) 88 0.00 12,345 0.01
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *1,360,783 *1.06 20,652 0.02

* Include the holding of 1,104,207 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 20 189.65
Purchase 80 189.65
Purchase 32 189.36
Purchase 1 185.232
Purchase 1 184.622
Purchase 1 186.212
Purchase 1 186.382
Purchase 1 182.272
Purchase 1 185.912
Purchase 1 185.762
Purchase 1 185.272
Purchase 1 185.722
Purchase 1 185.742
Purchase 50 190.09
Purchase 21 190.09
Purchase 22 190.09
Purchase 2 190.09
Purchase 5 190.09
Purchase 100 189.36
Purchase 619 189.36
Purchase 1,078 189.36
Sale 232 181.57
Sale 116 181.57
Sale 77 181.57
Sale 77 181.57
Sale 45 185.87
Sale 5 185.87
Sale 2 185.87
Sale 2 185.87
Sale 38 185.87
Sale 6 185.87
Sale 2 185.87
Sale 25 185.58
Sale 75 185.58
Sale 86 186.14
Sale 100 184.78
Sale 14 186.13
Sale 100 186.22
Sale 100 190.01
Sale 100 187.54
Sale 100 187.45
Sale 100 187.45
Sale 100 185.02
Sale 100 184.75
Sale 100 190.16
Sale 92 186.29
Sale 100 187.47
Sale 100 187.47
Sale 50 186.13
Sale 100 184.93
Sale 75 185.4
Sale 25 185.39
Sale 80 186.48
Sale 20 186.46
Sale 21 185.12
Sale 69 185.12
Sale 10 185.12
Sale 90 185.87
Sale 10 185.87
Sale 91 186.32
Sale 9 186.32
Sale 17 185.37
Sale 71 185.37
Sale 4 185.37
Sale 8 185.37
Total Purchases 2,039
Total Sales 2,744

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 16/06/2020
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEFIFFDRTIRLII